By expenditures
| Name | Title | Type |
|---|---|---|
| Heather Lemieux | Finance Director | Auditee |
| Sharon Euerle | SHARON.EUERLE@CO.MEEKER.MN.US | Auditee |
| Miranda Wendlandt | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 368940 | 2024 | 2025-09-30 | Cliftonlarsonallen LLP | $5.34M |
| 323197 | 2023 | 2024-09-30 | Cliftonlarsonallen LLP | $3.78M |
| 26710 | 2022 | 2023-09-21 | Cliftonlarsonallen LLP | $3.16M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 368940 | 2024 | 2025-09-30 | 1156596 | 2024-006 | Material Weakness | Yes | I |
| 368940 | 2024 | 2025-09-30 | 1156595 | 2024-006 | Material Weakness | Yes | I |
| 368940 | 2024 | 2025-09-30 | 1156594 | 2024-006 | Material Weakness | Yes | I |
| 368940 | 2024 | 2025-09-30 | 1156593 | 2024-005 | Material Weakness | Yes | E |
| 368940 | 2024 | 2025-09-30 | 1156592 | 2024-005 | Material Weakness | Yes | E |
| 368940 | 2024 | 2025-09-30 | 1156591 | 2024-005 | Material Weakness | Yes | E |
| 368940 | 2024 | 2025-09-30 | 1156590 | 2024-004 | Material Weakness | Yes | AB |
| 368940 | 2024 | 2025-09-30 | 1156589 | 2024-004 | Material Weakness | Yes | AB |
| 368940 | 2024 | 2025-09-30 | 1156588 | 2024-004 | Material Weakness | Yes | AB |
| 323197 | 2023 | 2024-09-30 | 1076873 | 2023-005 | Significant Deficiency | Yes | E |
| 323197 | 2023 | 2024-09-30 | 1076872 | 2023-005 | Significant Deficiency | Yes | E |
| 323197 | 2023 | 2024-09-30 | 1076871 | 2023-005 | Significant Deficiency | Yes | E |
| 323197 | 2023 | 2024-09-30 | 1076870 | 2023-004 | Significant Deficiency | - | L |
| 323197 | 2023 | 2024-09-30 | 1076869 | 2023-004 | Significant Deficiency | - | L |
| 323197 | 2023 | 2024-09-30 | 1076868 | 2023-004 | Significant Deficiency | - | L |
| 323197 | 2023 | 2024-09-30 | 500431 | 2023-005 | Significant Deficiency | Yes | E |
| 323197 | 2023 | 2024-09-30 | 500430 | 2023-005 | Significant Deficiency | Yes | E |
| 323197 | 2023 | 2024-09-30 | 500429 | 2023-005 | Significant Deficiency | Yes | E |
| 323197 | 2023 | 2024-09-30 | 500428 | 2023-004 | Significant Deficiency | - | L |
| 323197 | 2023 | 2024-09-30 | 500427 | 2023-004 | Significant Deficiency | - | L |
| 323197 | 2023 | 2024-09-30 | 500426 | 2023-004 | Significant Deficiency | - | L |
| 26710 | 2022 | 2023-09-21 | 611821 | 2022-005 | Significant Deficiency | - | E |
| 26710 | 2022 | 2023-09-21 | 611820 | 2022-005 | Significant Deficiency | - | E |
| 26710 | 2022 | 2023-09-21 | 611819 | 2022-005 | Significant Deficiency | - | E |
| 26710 | 2022 | 2023-09-21 | 611818 | 2022-004 | Significant Deficiency | - | I |
| 26710 | 2022 | 2023-09-21 | 35379 | 2022-005 | Significant Deficiency | - | E |
| 26710 | 2022 | 2023-09-21 | 35378 | 2022-005 | Significant Deficiency | - | E |
| 26710 | 2022 | 2023-09-21 | 35377 | 2022-005 | Significant Deficiency | - | E |
| 26710 | 2022 | 2023-09-21 | 35376 | 2022-004 | Significant Deficiency | - | I |